The Relationship Between CD4+CD25+CD127- Regulatory T Cells and Inflammatory Response and Outcome During Shock States

Overview

Journal Crit Care

Specialty Critical Care

Date 2010 Feb 17

PMID 20156359

Citations 38

Authors

Francois Hein

Frederic Massin

Aurelie Cravoisy-Popovic

Damien Barraud

Bruno Levy

Pierre-Edouard Bollaert

Sebastien Gibot

Affiliations

Soon will be listed here.

Abstract

Introduction: Although regulatory T lymphocytes (Tregs) have a pivotal role in preventing autoimmune diseases and limiting chronic inflammatory conditions, they may also block beneficial immune responses by preventing sterilizing immunity to certain pathogens.

Methods: To determine whether naturally occurring Treg cells have a role in inflammatory response and outcome during shock state we conducted an observational study in two adult ICUs from a university hospital. Within 12 hours of admission, peripheral whole blood was collected for the measurement of cytokines and determination of lymphocyte count. Sampling was repeated at day three, five and seven. Furthermore, an experimental septic shock was induced in adult Balb/c mice through caecal ligation and puncture.

Results: Forty-three patients suffering from shock (26 septic, 17 non septic), and 7 healthy volunteers were included. The percentage of Tregs increased as early as 3 days after the onset of shock, while their absolute number remained lower than in healthy volunteers. A similar pattern of Tregs kinetics was found in infected and non infected patients. Though there was an inverse correlation between severity scores and Tregs percentage, the time course of Tregs was similar between survivors and non survivors. No relation between Tregs and cytokine concentration was found. In septic mice, although there was a rapid increase in Treg cells subset among splenocytes, antibody-induced depletion of Tregs before the onset of sepsis did not alter survival.

Conclusions: These data argue against a determinant role of Tregs in inflammatory response and outcome during shock states.

Citing Articles

Th17/Treg balance: the bloom and wane in the pathophysiology of sepsis.

Liu X, Chen L, Peng W, Deng H, Ni H, Tong H Front Immunol. 2024; 15:1356869.

PMID: 38558800 PMC: 10978743. DOI: 10.3389/fimmu.2024.1356869.

Destabilisation of T cell-dependent humoral immunity in sepsis.

Davies K, McLaren J Clin Sci (Lond). 2024; 138(1):65-85.

PMID: 38197178 PMC: 10781648. DOI: 10.1042/CS20230517.

Temporal changes in regulatory T cell subsets defined by the transcription factor Helios in stroke and their potential role in stroke-associated infection: a prospective case-control study.

Lukasik M, Telec M, Kazmierski R, Wojtasz I, Andrzejewska-Gorczynska N, Kociemba W J Neuroinflammation. 2023; 20(1):275.

PMID: 37996909 PMC: 10666369. DOI: 10.1186/s12974-023-02957-w.

The Role of the Intravenous IgA and IgM-Enriched Immunoglobulin Preparation in the Treatment of Sepsis and Septic Shock.

Berlot G, Zanchi S, Moro E, Tomasini A, Bixio M J Clin Med. 2023; 12(14).

PMID: 37510760 PMC: 10380743. DOI: 10.3390/jcm12144645.

CD19CD24CD38 regulatory B cells deficiency revealed severity and poor prognosis in patients with sepsis.

Wang C, Xu H, Gao R, Leng F, Huo F, Li Y BMC Immunol. 2022; 23(1):54.

PMID: 36357845 PMC: 9648441. DOI: 10.1186/s12865-022-00528-x.

References

Vignali D, Collison L, Workman C . How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-32. PMC: 2665249. DOI: 10.1038/nri2343. View

Scumpia P, Delano M, Kelly K, OMalley K, Efron P, McAuliffe P . Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol. 2006; 177(11):7943-9. DOI: 10.4049/jimmunol.177.11.7943. View

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

Antonelli M, Levy M, Andrews P, Chastre J, Hudson L, Manthous C . Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med. 2007; 33(4):575-90. DOI: 10.1007/s00134-007-0531-4. View

Hotchkiss R, Karl I . The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348(2):138-50. DOI: 10.1056/NEJMra021333. View

Shevach E . Regulatory T cells in autoimmmunity*. Annu Rev Immunol. 2000; 18:423-49. DOI: 10.1146/annurev.immunol.18.1.423. View

Giamarellos-Bourboulis E, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I . Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care. 2006; 10(6):R166. PMC: 1794479. DOI: 10.1186/cc5111. View

Vincent J, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter P . Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998; 26(11):1793-800. DOI: 10.1097/00003246-199811000-00016. View

Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View

10.

Brun-Buisson C, Meshaka P, Pinton P, Vallet B . EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004; 30(4):580-8. DOI: 10.1007/s00134-003-2121-4. View

11.

Oberholzer A, Oberholzer C, Moldawer L . Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001; 16(2):83-96. DOI: 10.1097/00024382-200116020-00001. View

12.

Fehervari Z, Sakaguchi S . CD4+ Tregs and immune control. J Clin Invest. 2004; 114(9):1209-17. PMC: 524236. DOI: 10.1172/JCI23395. View

13.

Le Gall J, Lemeshow S, Saulnier F . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270(24):2957-63. DOI: 10.1001/jama.270.24.2957. View

14.

Venet F, Chung C, Kherouf H, Geeraert A, Malcus C, Poitevin F . Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2008; 35(4):678-86. PMC: 2789433. DOI: 10.1007/s00134-008-1337-8. View

15.

Monneret G, Debard A, Venet F, Bohe J, Hequet O, Bienvenu J . Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med. 2003; 31(7):2068-71. DOI: 10.1097/01.CCM.0000069345.78884.0F. View

16.

Heuer J, Zhang T, Zhao J, Ding C, Cramer M, Justen K . Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol. 2005; 174(11):7141-6. DOI: 10.4049/jimmunol.174.11.7141. View

17.

Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z . Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006; 212:8-27. DOI: 10.1111/j.0105-2896.2006.00427.x. View

18.

Venet F, Pachot A, Debard A, Bohe J, Bienvenu J, Lepape A . Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med. 2005; 32(11):2329-31. DOI: 10.1097/01.ccm.0000145999.42971.4b. View

19.

Hotchkiss R, Swanson P, Cobb J, Jacobson A, Buchman T, KARL I . Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med. 1997; 25(8):1298-307. DOI: 10.1097/00003246-199708000-00015. View

20.

Monneret G, Venet F, Pachot A, Lepape A . Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2007; 14(1-2):64-78. PMC: 2078557. DOI: 10.2119/2007-00102.Monneret. View